Key Questions to Identify Infection Source in COPD Exacerbation
To determine how a patient with acute COPD exacerbation acquired their infection, focus your history on recent upper respiratory symptoms, smoking status, environmental exposures, and severity of underlying disease—as these directly predict the likely pathogen and transmission route.
Essential Historical Questions
Recent Viral Prodrome
- Ask specifically about preceding upper respiratory tract symptoms (runny nose, sore throat, nasal congestion) in the days before worsening dyspnea and purulent sputum 1
- Approximately one-third of COPD exacerbations are triggered by viral infections (rhinovirus, coronavirus, influenza B, parainfluenza), which then predispose to bacterial superinfection 1
- The temporal sequence matters: viral symptoms typically precede the bacterial exacerbation by several days 1
Smoking History and Current Status
- Determine if the patient is a current smoker versus former smoker 1
- Current smokers have significantly higher rates of bacterial colonization with Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae even during stable periods 1
- Current smoking impairs mucociliary clearance and creates a cycle favoring bacterial overgrowth 1
Disease Severity Assessment
- Establish the patient's baseline FEV₁ or severity stage 2
- This is critical because pathogen distribution varies by disease severity:
- Patients with more severe airflow limitation are at higher risk for colonization with more resistant organisms 4
Exposure History
- Recent sick contacts, particularly household members with respiratory infections
- Healthcare exposures: Recent hospitalizations, emergency department visits, or antibiotic use (increases risk of resistant organisms)
- Occupational or environmental exposures to respiratory irritants that may have triggered the exacerbation 5
Baseline Colonization Status
- History of previous sputum cultures showing specific organisms 1
- Many COPD patients are colonized during stable periods, and exacerbations often involve acquisition of a new strain of a pre-existing organism rather than a completely new pathogen 1
Clinical Examination Findings to Document
Sputum Characteristics
- Assess sputum purulence using a color chart if available 6
- Increasing sputum purulence is the single best clinical predictor of bacterial infection (AUROC 0.739) 6
- Purulent sputum correlates with bacterial pathogens better than fever, non-productive cough, or dyspnea alone 3
Symptom Pattern
- Document the triad: increased sputum volume, increased sputum purulence, and worsening dyspnea 1, 7
- Presence of two or more of these features suggests bacterial etiology requiring antibiotics 8
Common Pitfalls to Avoid
Do not assume all exacerbations are infectious: Approximately 25-50% of exacerbations have non-infectious triggers 9. Always consider and exclude:
- Cardiac failure (especially with orthopnea, displaced apex beat, history of MI) 10
- Pulmonary embolism (immobilization, DVT history, malignancy) 10
- Pneumothorax
- Pneumonia (requires chest radiograph if suspected) 10
Do not rely solely on fever: Fever is not a reliable indicator of bacterial infection in COPD exacerbations; sputum purulence is far more predictive 3
Recognize that viral and bacterial infections often coexist: Viral infections damage mucociliary clearance and impair macrophage function, creating conditions for bacterial superinfection 1
Risk Stratification for Pathogen Prediction
The history should enable you to stratify patients into risk categories:
- Low-risk (mild-moderate disease, no recent antibiotics): Typical pathogens (S. pneumoniae, H. influenzae, M. catarrhalis) 3, 4
- High-risk (severe disease, FEV₁ <35%, recent antibiotics, frequent exacerbations): Consider Pseudomonas and resistant Gram-negatives 2, 4
- Recent viral prodrome: Mixed viral-bacterial etiology likely 1